-
Instacart gets off to a flying start on Wall Street: +12%, but after +40% during the session.
- Moderna terminates production of its vaccine at Lonza's Visp site.
- Philip Morris calls into question its $2 billion bet on pharmaceuticals by considering putting its dedicated division up for sale, according to the WSJ.
- Walt Disney plans to invest $60 billion in its parks, experiences and products division over 10 years, which does not seem to please the market.
- Ford avoids strike in Canada thanks to union agreement.
- Boeing slightly revises upwards its 20-year demand forecast for China.
- SoftBank to receive $5.1 billion from successful Arm Holdings IPO in the US.
- Intel to launch "Core Ultra Meteor Lake" chips in December.
- AstraZeneca buys Pfizer's gene therapy portfolio for rare diseases for $1 billion.
- Ryanair is the subject of a new antitrust investigation in Italy.
- Uber, DoorDash and Grubhub have the right to challenge New York City delivery fees in court, according to a US judge.
- Talanx launches €300 million capital increase.
- Swedish Orphan recovers 6 billion kronor from its capital increase.
Main earnings reports today: Fedex, General Mills, Raymond James, Bâloise...
Global markets live: Moderna, Philip Morris, Walt Disney, Intel, Uber...
Every day, the MarketScreener team selects the most important news about listed companies across the world. Here's a short recap for your convenience: